OpenAlex
PricingAboutJobs
Log inGet started
Work

SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications

HTML PDF

Year: 2021
Type: review
Source: The Lancet
DOI: 10.1016/s0140-6736(21)00536-5
Authors: Emily Brown, Hiddo J L Heerspink, Daniel J Cuthbertson, John P H Wilding
Institutions: University of Liverpool, Liverpool University Hospitals NHS Foundation Trust, University Medical Center Groningen, University of Groningen
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: SGLT2 inhibitors, GLP-1 receptor agonists, type 2 diabetes, glucose-lowering therapy, cardiovascular outcomes, heart failure, chronic kidney disease, cardiorenal disease, diabetic ketoacidosis, medullary thyroid carcinoma, pancreatitis, obesity, weight loss, end-stage renal disease, renal protection
SDG: Good health and well-being

Open Access status: bronze

Funders: Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Boehringer Ingelheim, University of Liverpool, Novo Nordisk, Ipsen, Janssen Pharmaceuticals
OpenAlex ID: W3173421961
FWCI: 12.53
Cites: 91
Cited by: 679
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security